<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>51选刊 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-08T02:15:09+08:00</updated>
  <subtitle>如何选择SCI期刊，也是一门技巧。这里我们帮助大家选择拟投稿的SCI期刊！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>这本一区期刊对国人非常友好，审稿快，发文量增加，今年影响因子5分+</title>
    <updated>2021-01-07T22:55:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/rLd1OFWOecgS55ygO5VJag</id>
    <link href="https://mp.weixin.qq.com/s/rLd1OFWOecgS55ygO5VJag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武汉大学中南医院Med Res Rev综述：口腔微生物组与前列腺疾病</title>
    <updated>2021-01-07T22:55:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/Fl1x3zTzHfDu2_3NyZGJsQ</id>
    <link href="https://mp.weixin.qq.com/s/Fl1x3zTzHfDu2_3NyZGJsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>可望不可及：2020年全球高被引论文Top 10</title>
    <updated>2021-01-07T22:55:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/IrUflLYOoIXAbh4uIUlC8g</id>
    <link href="https://mp.weixin.qq.com/s/IrUflLYOoIXAbh4uIUlC8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今年5分+，明年或超7+，这本SCI两个月可接受~</title>
    <updated>2021-01-07T22:55:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/zwXGw89mysuhdYCAzGw3Xg</id>
    <link href="https://mp.weixin.qq.com/s/zwXGw89mysuhdYCAzGw3Xg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年发文1000篇，2个月接受，国人友好，影响因子持续走高，今年16分+，这本SCI明年将超17分+</title>
    <updated>2021-01-07T22:55:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/TXXhwYqzJi6v52j0m3mfSA</id>
    <link href="https://mp.weixin.qq.com/s/TXXhwYqzJi6v52j0m3mfSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Call for Papers (IF 5.186 )：3个月接受，截稿时间2021年8月31日</title>
    <updated>2021-01-07T22:55:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/QLlaYNMEYm833Es7dQtpGg</id>
    <link href="https://mp.weixin.qq.com/s/QLlaYNMEYm833Es7dQtpGg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创刊2年入选SCI，今年首个IF超5分，明年第二个IF或超7分，年发文超1000篇</title>
    <updated>2021-01-07T22:55:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/58IRjs6jJE8eNeIq8uP2rQ</id>
    <link href="https://mp.weixin.qq.com/s/58IRjs6jJE8eNeIq8uP2rQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个IF超5分，国人友好，2个月接受，今年第二个也超5分，年发文1200篇</title>
    <updated>2021-01-07T22:55:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/mWaa6SJZIzvlbLDFii2SsA</id>
    <link href="https://mp.weixin.qq.com/s/mWaa6SJZIzvlbLDFii2SsA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本国产SCI，首个IF就进中科院二区，OA期刊且不交版面费</title>
    <updated>2021-01-06T22:25:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/013o7JEwE2s8NcXoUxExbA</id>
    <link href="https://mp.weixin.qq.com/s/013o7JEwE2s8NcXoUxExbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚被SCI收录的国产英文刊，明年第一个IF或近4分 | 精彩论文:肝癌的快速生长程序</title>
    <updated>2021-01-06T22:25:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/1gc3VpycHqigDeitQQEpEg</id>
    <link href="https://mp.weixin.qq.com/s/1gc3VpycHqigDeitQQEpEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Call for Papers (IF 5.186 )：3个月接受，截稿时间2021年8月31日</title>
    <updated>2021-01-06T22:25:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/vVHmP4__2iM8rf3zFUUW1A</id>
    <link href="https://mp.weixin.qq.com/s/vVHmP4__2iM8rf3zFUUW1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本去年刚被SCI收录的国产期刊，影响因子大涨，明年将翻倍！</title>
    <updated>2021-01-06T22:25:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/NxV39FanZjqJ7WxJr2pKgA</id>
    <link href="https://mp.weixin.qq.com/s/NxV39FanZjqJ7WxJr2pKgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本SCI一审只需3周，今年首超5分，年发文超2700篇</title>
    <updated>2021-01-06T22:25:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/m1yva1_AgGwp-SDI5fKxsw</id>
    <link href="https://mp.weixin.qq.com/s/m1yva1_AgGwp-SDI5fKxsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​这本SCI是中科院一区top期刊，国际认可度高，连续多年7分+</title>
    <updated>2021-01-06T22:25:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/hP-9EzvFElDnzmt8WvH0rw</id>
    <link href="https://mp.weixin.qq.com/s/hP-9EzvFElDnzmt8WvH0rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本年发文超3000篇SCI，今年4分，明年或可突破5分</title>
    <updated>2021-01-06T22:25:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/YwIJ35lyIF6yFPbpQSVDLA</id>
    <link href="https://mp.weixin.qq.com/s/YwIJ35lyIF6yFPbpQSVDLA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年发文量5000篇，IF连续多年3分+，这本Q2区SCI值得关注~</title>
    <updated>2021-01-06T22:25:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/nhNWaewfP_HR4mNBPwxDZA</id>
    <link href="https://mp.weixin.qq.com/s/nhNWaewfP_HR4mNBPwxDZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本专业期刊国人投稿少，平均2个月接受，影响因子整体上涨</title>
    <updated>2021-01-05T22:59:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/eV1BggAVCfUTxVVs_LBNwg</id>
    <link href="https://mp.weixin.qq.com/s/eV1BggAVCfUTxVVs_LBNwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>适合国人投稿：这本SCI年发文1200篇，多年一直徘徊在7~8分，非常稳定</title>
    <updated>2021-01-05T22:59:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/HTGzdM3dCvwmDQGOmKuwvA</id>
    <link href="https://mp.weixin.qq.com/s/HTGzdM3dCvwmDQGOmKuwvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这本深受国人喜欢的SCI，发文量和IF均逐年增加，今年近10分，明年将超10分，两个月接受</title>
    <updated>2021-01-05T22:59:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/FuorDWnXwvg0MMgNasm8VQ</id>
    <link href="https://mp.weixin.qq.com/s/FuorDWnXwvg0MMgNasm8VQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今年首个IF破15分，位居Q1区 | 这本SCI两三个月可接受，年发文增长趋势喜人</title>
    <updated>2021-01-05T22:59:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/2s--w8jc1edssFCDasKaRQ</id>
    <link href="https://mp.weixin.qq.com/s/2s--w8jc1edssFCDasKaRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>